©The Author(s) 2023.
World J Clin Cases. Sep 16, 2023; 11(26): 6240-6245
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6240
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6240
Table 1 Basic characteristics of the reported cases
| ID | Ref. | Age (yr) | Diagnosis | Treatment | Follow-up outcome |
| 1 | [5] | 43 | Squamous cell carcinoma of the ovary | Paclitaxel and cisplatin | Vaginal metastases |
| 2 | [11] | 52 | Squamous cell carcinoma of the ovary | Paclitaxel and cisplatin | Without metastases |
| 3 | [12] | 47 | Squamous cell carcinoma of the ovary | Paclitaxel and cisplatin | Liver metastases |
| 4 | [13] | 45 | Squamous cell carcinoma of the ovary | Paclitaxel and cisplatin | Pelvic metastases |
| 5 | [10] | 31 | Squamous cell carcinoma of the ovary | Paclitaxel and cisplatin | Without recurrence |
| 6 | [9] | 46 | Squamous cell carcinoma of the ovary with lung metastasis | Paclitaxel and cisplatin | Tumor progression and aggravation |
| 7 | Our case | 57 | Squamous cell carcinoma of the ovary and uterus | Paclitaxel and cisplatin | Without metastases |
- Citation: Cai Z, Yang GL, Li Q, Zeng L, Li LX, Song YP, Liu FR. Squamous cell carcinoma associated with endometriosis in the uterus and ovaries: A case report. World J Clin Cases 2023; 11(26): 6240-6245
- URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6240.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i26.6240